Novozymes A/S (NZYM-B.CO) Financials
NZYM-B.CO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 28.4 billion | 14.0 billion |
2023-09-30 | 28.5 billion | 13.6 billion |
2023-06-30 | 28.2 billion | 14.4 billion |
2023-03-31 | 28.3 billion | 15.0 billion |
NZYM-B.CO Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 518.0 million | ? |
2023-09-30 | 1.1 billion | ? |
2023-06-30 | 581.0 million | ? |
2023-03-31 | -114.0 million | ? |
NZYM-B.CO Net Income
Date | Net Income |
---|---|
2023-12-31 | 698.0 million |
2023-09-30 | 929.0 million |
2023-06-30 | 614.0 million |
2023-03-31 | 801.0 million |
NZYM-B.CO Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | - | - | 369.0 million |
2023-09-30 | 1.2 billion | - | 374.0 million |
2023-06-30 | 1.1 billion | - | 394.0 million |
2023-03-31 | 1.2 billion | - | 412.0 million |
NZYM-B.CO Shares Outstanding
NZYM-B.CO Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 604.0 million | 524.0 million | 842.0 million | - |
2023-09-30 | 475.0 million | 461.0 million | 236.0 million | 531.0 million |
2023-06-30 | 549.0 million | 515.0 million | 231.0 million | 594.0 million |
2023-03-31 | 428.0 million | 517.0 million | 251.0 million | 639.0 million |
NZYM-B.CO Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 4.6 billion | 2.1 billion |
2023-09-30 | 4.5 billion | 2.1 billion |
2023-06-30 | 4.2 billion | 1.9 billion |
2023-03-31 | 4.6 billion | 2.1 billion |
NZYM-B.CO
Price: DKK397.40
Dividend Yield: 2.60%
Forward Dividend Yield: 1.06%
Payout Ratio: 38.60%
Dividend Per Share: 4.20 DKK
Earnings Per Share: 10.88 DKK
P/E Ratio: 34.33
Exchange: CPH
Sector: Basic Materials
Industry: Specialty Chemicals
Volume: 123455
Market Capitalization: 185.1 billion
Average Dividend Frequency: 1
Years Paying Dividends: 23
DGR3: 30.00%
DGR5: 21.27%
DGR10: 18.34%
DGR20: 18.03%